Exfoliative dermatitis
☆ AI Dermatology — Free Service
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Ninu awọn abajade 2022 Stiftung Warentest lati Jẹmánì, itẹlọrun alabara pẹlu ModelDerm jẹ kekere diẹ ju pẹlu awọn ijumọsọrọ telemedicine isanwo.
Red (burning) Skin Syndrome — Erythema ati iwọn lori gbogbo ara jẹ́ ààmì àìsàn àkọ́kọ́ ti Exfoliative dermatitis.
relevance score : -100.0%
ReferencesErythroderma jẹ ipo awọ to ṣọwọn, ṣugbọn pataki. Botilẹjẹpe idi gangan rẹ ko mọ nigbagbogbo, o le jẹ abajade ti iṣesi oogun tabi akàn ti o wa labẹ. Akàn kan ti o wọpọ ti o ni ibatan si dermatitis exfoliative ni lymphoma T‑cell ti o ni awọ, ti o le ma ṣe afihan awọn aami aisan fun awọn oṣu tabi paapaa awọn ọdun lẹhin ti ipo awọ ara bẹrẹ. Nigbagbogbo, a nilo ile‑iwosan fun ayẹwo ati itọju akọkọ. Awọn alaisan ti o ni arun ti o fa oogun maa n ni iwoye igba pipẹ to dara, botilẹjẹpe awọn ọran ti ko ni idi ti o han gbangba ṣọ lati ni iṣẹ‑ṣiṣe loorekoore ati gbigbemi. Asọtẹlẹ fun awọn ọran ti o ni ibatan si akàn maa n da lori bi arun naa ṣe nlọsiwaju.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Erythroderma is a rare but serious skin condition. While the exact cause is often unknown, it can be triggered by a drug reaction or an underlying cancer. One common cancer linked to exfoliative dermatitis is cutaneous T-cell lymphoma, which might not show symptoms for months or even years after the skin condition starts. Usually, hospitalization is needed for initial assessment and treatment. Patients with drug-induced disease generally have a good long-term outlook, though cases without a clear cause tend to have a recurring and remitting course. The prognosis for cases linked to cancer typically depends on how the cancer progresses.
Nigbagbogbo, o maa n ṣe afihan pupa ti o tan kaakiri ati ibora ti o ju 90 % ti ara lọ. Ipo yii jẹ ami ti o han ti ọpọlọpọ awọn ọran ilera abẹlẹ bii psoriasis, àléfọ, tabi idahun si awọn oogun kan.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
It characteristically demonstrates diffuse erythema and scaling of greater than 90% of the body surface area. It is a reaction pattern and cutaneous manifestation of a myriad of underlying ailments, including psoriasis and eczema, or a reaction to the consumption of certain drugs.
Idi tó wọ́pọ̀ jùlọ fún erythroderma ni ìtẹ̀síwájú àrùn awọ‑ara bíi psoriasis, contact dermatitis, seborrheic dermatitis, lichen planus, pityriasis rubra pilaris, tàbí ìbáṣepọ̀ pẹ̀lú àwọn ohun èlò tó ń fa àìlera, bíi lílo corticosteroids àgbègbè. Iṣe àìlera yìí kéré ní àkókò ìbẹ̀rẹ̀, ṣùgbọ́n ó lè hàn ní àwọn ọ̀ràn lymphoma T‑cell. Nítorí pé ó ṣe pàtàkì láti yà á kúrò ní T‑cell lymphoma, a máa ń ṣe biopsy.